← FDA DRUG APPROVALS

FDA ANDA · ANDA091363

ZOLEDRONIC ACID

Sponsor: DR REDDYS LABS LTD

APPLICATION
ANDA091363
TYPE
ANDA
ORIGINAL APPROVAL
2013-03-29
LATEST ACTION
2023-03-07
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ZOLEDRONIC ACIDPrescription
ZOLEDRONIC ACID EQ 5MG BASE/100ML · INJECTABLE · INTRAVENOUS

Approval history

2023-03-07Labeling · Supplement 10 · standardAP
2017-09-18Labeling · Supplement 6 · standardAP
2015-09-02Labeling · Supplement 4 · standardAP
2015-04-09Labeling · Supplement 1 · standardAP
2013-03-29OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →